IGC Pharma, Inc. (IGC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.09 | +59.1% |
| 2024 | $-0.22 | — |
| 2017 | $-0.07 | +58.8% |
| 2016 | $-0.17 | +45.2% |
| 2015 | $-0.31 | +16.2% |
| 2014 | $-0.37 | -15.6% |
| 2013 | $-0.32 | +88.0% |
| 2012 | $-2.66 | -98.5% |
| 2011 | $-1.34 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.09 | +59.1% |
| 2024 | $-0.22 | — |
| 2017 | $-0.07 | +58.8% |
| 2016 | $-0.17 | +45.2% |
| 2015 | $-0.31 | +16.2% |
| 2014 | $-0.37 | -15.6% |
| 2013 | $-0.32 | +88.0% |
| 2012 | $-2.66 | -98.5% |
| 2011 | $-1.34 | — |